AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Whitehawk Therapeutics, Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG002WN7DV9
3.21▼ 0.04 (-1.23%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
3.25
Day's Range
3.08 – 3.26
52-Week Range
1.97 – 5.50
Volume
222.6K
Avg Volume
338.7K
Share Statistics
Shares Outstanding
Employees
23
Exchange
XNAS
Listed
2021-08-27
Share count as of August 3, 2026

Whitehawk Therapeutics, Inc. Common Stock (WHWK) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Whitehawk Therapeutics, Inc. Common Stock (WHWK)
What is Whitehawk Therapeutics, Inc. Common Stock's Market Cap?
Whitehawk Therapeutics, Inc. Common Stock's Market Cap is $183.0M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Enterprise Value?
Whitehawk Therapeutics, Inc. Common Stock's Enterprise Value is -$7.0M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's EV / EBITDA?
Whitehawk Therapeutics, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Revenue (TTM)?
Whitehawk Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Net Income (TTM)?
Whitehawk Therapeutics, Inc. Common Stock's Net Income (TTM) is -$79.8M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's EBITDA?
Whitehawk Therapeutics, Inc. Common Stock's EBITDA is -$86.0M, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?
Whitehawk Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.40, based on as-reported figures from SEC (XBRL) filings.
What is Whitehawk Therapeutics, Inc. Common Stock's Net Debt?
Whitehawk Therapeutics, Inc. Common Stock's Net Debt is -$190.0M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · WHWKAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total revenue
YoY growth-100.0%-100.0%-100.0%
Operating expenses
Selling, general and administrative
Research and development
Cost of goods sold
Total operating expenses
% of revenue———
Loss from operations
% of revenue———
Other income (expense)
Gain on sale of business
Foreign exchange loss
Other income
Interest income
Total other income (expense), net
Loss (income) before income tax expense——
Income tax expense (benefit)——
Net (loss) income
% of revenue———
Other comprehensive (loss) income:
Unrealized (loss) gain on investments, net of tax
Comprehensive (loss) income
Net (loss) income per share:
Basic (in dollars per share)
Diluted (in dollars per share)—